PortfoliosLab logoPortfoliosLab logo
INCY vs. IVZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INCY vs. IVZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Incyte Corporation (INCY) and Invesco Ltd. (IVZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INCY achieves a 1.89% return, which is significantly lower than IVZ's 6.54% return. Over the past 10 years, INCY has underperformed IVZ with an annualized return of 2.27%, while IVZ has yielded a comparatively higher 4.48% annualized return.


INCY

1D
-1.70%
1M
2.11%
YTD
1.89%
6M
4.07%
1Y
46.34%
3Y*
18.14%
5Y*
3.15%
10Y*
2.27%

IVZ

1D
0.73%
1M
0.64%
YTD
6.54%
6M
8.44%
1Y
98.16%
3Y*
25.82%
5Y*
3.83%
10Y*
4.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INCY vs. IVZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INCY
Incyte Corporation
1.89%43.00%10.00%-21.83%9.43%-15.61%-0.39%37.32%-32.86%-5.55%
IVZ
Invesco Ltd.
6.54%56.94%3.02%6.05%-18.71%35.56%3.06%14.91%-52.05%24.67%

Correlation

The correlation between INCY and IVZ is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Aug 25, 1995

0.27

Fundamentals

EPS

INCY:

$7.06

IVZ:

-$0.62

PS Ratio

INCY:

3.81

IVZ:

1.96

Total Revenue (TTM)

INCY:

$5.36B

IVZ:

$6.38B

Gross Profit (TTM)

INCY:

$3.76B

IVZ:

$2.75B

EBITDA (TTM)

INCY:

$1.80B

IVZ:

$1.38B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INCY vs. IVZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INCY
INCY Risk / Return Rank: 7979
Overall Rank
INCY Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
INCY Sortino Ratio Rank: 7979
Sortino Ratio Rank
INCY Omega Ratio Rank: 7777
Omega Ratio Rank
INCY Calmar Ratio Rank: 8080
Calmar Ratio Rank
INCY Martin Ratio Rank: 7979
Martin Ratio Rank

IVZ
IVZ Risk / Return Rank: 9292
Overall Rank
IVZ Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IVZ Sortino Ratio Rank: 9393
Sortino Ratio Rank
IVZ Omega Ratio Rank: 9292
Omega Ratio Rank
IVZ Calmar Ratio Rank: 9090
Calmar Ratio Rank
IVZ Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INCY vs. IVZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Incyte Corporation (INCY) and Invesco Ltd. (IVZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INCYIVZDifference
Sharpe ratioReturn per unit of total volatility

-1.41

Sortino ratioReturn per unit of downside risk

-1.35

Omega ratioGain probability vs. loss probability

1.26

1.46

-0.20

Calmar ratioReturn relative to maximum drawdown

2.54

4.48

-1.94

Martin ratioReturn relative to average drawdown

5.67

12.09

-6.42

INCY vs. IVZ - Sharpe Ratio Comparison

The current INCY Sharpe Ratio is 1.41, which is lower than the IVZ Sharpe Ratio of 2.82. The chart below compares the historical Sharpe Ratios of INCY and IVZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INCYIVZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.41

2.82

-1.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.11

0.11

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.07

0.11

-0.05

Sharpe Ratio (All Time)

Calculated using the full available price history

0.21

0.18

+0.03

Drawdowns

INCY vs. IVZ - Drawdown Comparison

The maximum INCY drawdown since its inception was -98.54%, which is greater than IVZ's maximum drawdown of -83.91%. Use the drawdown chart below to compare losses from any high point for INCY and IVZ.


Loading charts...

Drawdown Indicators


INCYIVZDifference

Max Drawdown

Largest peak-to-trough decline

-98.54%

-83.91%

-14.63%

Max Drawdown (1Y)

Largest decline over 1 year

-18.33%

-22.03%

+3.70%

Max Drawdown (3Y)

Largest decline over 3 years

-33.83%

-36.52%

+2.69%

Max Drawdown (5Y)

Largest decline over 5 years

-41.53%

-53.40%

+11.87%

Max Drawdown (10Y)

Largest decline over 10 years

-66.47%

-79.72%

+13.25%

Current Drawdown

Current decline from peak

-34.08%

-4.93%

-29.15%

Average Drawdown

Average peak-to-trough decline

-59.91%

-36.00%

-23.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.19%

8.15%

+0.04%

Volatility

INCY vs. IVZ - Volatility Comparison

Incyte Corporation (INCY) and Invesco Ltd. (IVZ) have volatilities of 9.23% and 9.52%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INCYIVZDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.23%

9.52%

-0.29%

Volatility (6M)

Calculated over the trailing 6-month period

23.30%

25.49%

-2.19%

Volatility (1Y)

Calculated over the trailing 1-year period

33.04%

35.09%

-2.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.41%

36.58%

-7.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.28%

39.41%

-5.13%

Dividends

INCY vs. IVZ - Dividend Comparison

INCY has not paid dividends to shareholders, while IVZ's dividend yield for the trailing twelve months is around 3.07%.


PositionTTM20252024202320222021202020192018201720162015
INCY
Incyte Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IVZ
Invesco Ltd.
3.07%3.18%4.66%6.15%4.07%2.89%4.45%6.84%7.11%3.15%3.66%3.17%

Financials

INCY vs. IVZ - Financials Comparison

This section allows you to compare key financial metrics between Incyte Corporation and Invesco Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M800.00M1.00B1.20B1.40B1.60B1.80B20222023202420252026
1.27B
1.69B
(INCY) Total Revenue
(IVZ) Total Revenue
Values in USD except per share items

INCY vs. IVZ - Profitability Comparison

The chart below illustrates the profitability comparison between Incyte Corporation and Invesco Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
67.0%
Portfolio components
INCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a gross profit of 0.00 and revenue of 1.27B. Therefore, the gross margin over that period was 0.0%.

IVZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Invesco Ltd. reported a gross profit of 1.13B and revenue of 1.69B. Therefore, the gross margin over that period was 67.0%.

INCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported an operating income of 301.12M and revenue of 1.27B, resulting in an operating margin of 23.7%.

IVZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Invesco Ltd. reported an operating income of -1.46B and revenue of 1.69B, resulting in an operating margin of -86.2%.

INCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a net income of 303.33M and revenue of 1.27B, resulting in a net margin of 23.8%.

IVZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Invesco Ltd. reported a net income of -1.06B and revenue of 1.69B, resulting in a net margin of -62.7%.


Frequently Asked Questions


INCY and IVZ have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IVZ has higher volatility (9.52%) compared to INCY (9.23%). In terms of maximum drawdown, INCY dropped -98.54% vs IVZ's -83.91%.

IVZ currently has the higher Sharpe Ratio (2.82 vs 1.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INCY and IVZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer